AUPR690601A0 - Toxin associated with sudden infant death syndrome, and uses thereof - Google Patents

Toxin associated with sudden infant death syndrome, and uses thereof

Info

Publication number
AUPR690601A0
AUPR690601A0 AUPR6906A AUPR690601A AUPR690601A0 AU PR690601 A0 AUPR690601 A0 AU PR690601A0 AU PR6906 A AUPR6906 A AU PR6906A AU PR690601 A AUPR690601 A AU PR690601A AU PR690601 A0 AUPR690601 A0 AU PR690601A0
Authority
AU
Australia
Prior art keywords
death syndrome
infant death
sudden infant
toxin associated
toxin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPR6906A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Womens and Childrens Hospital Adelaide
Original Assignee
Womens and Childrens Hospital Adelaide
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Womens and Childrens Hospital Adelaide filed Critical Womens and Childrens Hospital Adelaide
Priority to AUPR6906A priority Critical patent/AUPR690601A0/en
Publication of AUPR690601A0 publication Critical patent/AUPR690601A0/en
Priority to PCT/AU2002/001085 priority patent/WO2003013601A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AUPR6906A 2001-08-10 2001-08-10 Toxin associated with sudden infant death syndrome, and uses thereof Abandoned AUPR690601A0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AUPR6906A AUPR690601A0 (en) 2001-08-10 2001-08-10 Toxin associated with sudden infant death syndrome, and uses thereof
PCT/AU2002/001085 WO2003013601A1 (en) 2001-08-10 2002-08-09 Toxin associated with sudden infant death syndrome, and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR6906A AUPR690601A0 (en) 2001-08-10 2001-08-10 Toxin associated with sudden infant death syndrome, and uses thereof

Publications (1)

Publication Number Publication Date
AUPR690601A0 true AUPR690601A0 (en) 2001-08-30

Family

ID=3830862

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPR6906A Abandoned AUPR690601A0 (en) 2001-08-10 2001-08-10 Toxin associated with sudden infant death syndrome, and uses thereof

Country Status (2)

Country Link
AU (1) AUPR690601A0 (en)
WO (1) WO2003013601A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112743395A (en) * 2019-10-31 2021-05-04 昆山市孚特莱电子设备有限公司 Method for repairing surface of exposure glass finished product

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8801723D0 (en) * 1988-05-06 1988-05-06 Staffan Normark FIBRONECTIN BINDING PROTEIN AS WELL AS IT'S PREPARATION

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112743395A (en) * 2019-10-31 2021-05-04 昆山市孚特莱电子设备有限公司 Method for repairing surface of exposure glass finished product

Also Published As

Publication number Publication date
WO2003013601A1 (en) 2003-02-20

Similar Documents

Publication Publication Date Title
AU2002331020A1 (en) Head protector for infants and small children
ZA200407868B (en) 17alpha-Alkyl-17beta-oxy-estratrienes, uses thereof and pharmaceutical preparations.
AU2002245199A1 (en) Sulfur-absorbent bed and fuel processing assembly incorporating the same
AU2002254343A1 (en) Halo-polymer nanocomposite compositions, methods, and products employing such compositions
AU2001280653A1 (en) Venturi cluster, and burners and methods employing such cluster
AU2001258229A1 (en) Alpha-amylase variants with altered 1,6-activity
AU2002359767A1 (en) Absorbent article with stabilized absorbent structure
ZA200207650B (en) Absorbent structure and absorbent articles containing the absorbent structure.
AU2002359805A1 (en) Absorbent article with stabilized absorbent structure
AU2002329873A1 (en) Halogenated calixpyrroles, calixpyridinopyrroles and calixpyridines, and uses thereof
AU2002226266A1 (en) Amine derivative with potassium channel regulatory function, its preparation and use
AU2003284616A1 (en) Shoulder belt, and baby band with the shoulder belt
AU2002243392A1 (en) Immunogenic proteoliposomes, and uses thereof
AU2001287065A1 (en) Modified carbon, silicon and germanium surfaces
AU2002224876A1 (en) Isolated luciferases and the use thereof
AUPR690601A0 (en) Toxin associated with sudden infant death syndrome, and uses thereof
AU2002342949A1 (en) Vaccine composition comprising at least two valences, one with enhanced adjuvant and not the other
AU2001291235A1 (en) 22108 and 47916, novel human thioredoxin family members and uses thereof
AU2002322167A1 (en) Toxin associated with sudden infant death syndrome, and uses thereof
AU2002320079A1 (en) Vaccines, immunotherapeutics and methods of using the same
HUP0401182A3 (en) Vaccine composition comprising at least two valences, one enhanced with adjuvant and not the other
MXPA03006162A (en) Mikanolide derivatives, their preparation and therapeutic uses.
AU2001265384A1 (en) 52906, 33408, and 12189, potassium channel family members and uses thereof
MXPA03007625A (en) Modified thrombopoietin with reduced immunogenicity.
AU2001243341A1 (en) 25324, 50287, 28899, 47007, and 42967 transferase family members and uses therefor